Episode 128: Debate of the Decade: RCTs in the Era of Precision Oncology
Healthcare Unfiltered
00:00
The Future of Precision Oncology
Vivek Kurzrock, Ray Booth: Are there scenarios where you would want to see in RCT? Let's reverse the position. Time may show that using immunotherapy and MSI locally advanced rectal cancer, maybe that is the next to Matnip. But we have to be careful if we say that for all of those other drugs, we're going to be so confident upfront that we just start using them.
Play episode from 52:16
Transcript
